Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial - Cascone, T; Leung, CH; Weissferdt, A (Nat Med, 2023)
et al.